Cost-Effectiveness of Edoxaban Compared With Other Licensed Noacs for the Prevention of Stroke and Systemic Embolic Events in the Uk

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.895
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcv80 - Cost-Effectiveness of Noacs in Prevention of Stroke and Systemic Embolism in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Cost-Effectiveness of New Oral Anticoagulants Compared With Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Potential Role of Edoxaban in Stroke Prevention Guidelines

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2011English

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2012English

Estimating the Cost-Effectiveness of Stroke Units in France Compared With Conventional Care

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2004English

NAVIGATE ESUS: Phase-Iii RCT Assessing Prevention of Stroke and Systemic Embolism in Patients With Embolic Stroke of Undetermined Source

Journal of the Neurological Sciences
Neurology
2015English

Pcv53 - Is Edoxaban More Cost-Effective Than Warfarin in Prevention of Stroke and Deep Vein Thrombosis?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy